Pregnant women with diabetes face unique risks during labor and delivery. The metabolic disturbances and organ involvement caused by diabetes make these pregnancies high-risk, requiring a specialized anesthesia approach. Diabetic parturients often have comorbidities such as hypertension, preeclampsia, autonomic neuropathy, diabetic nephropathy, and gastroparesis, which must be carefully managed. The primary goal of anesthesia management is to maintain maternal and fetal safety by stabilizing blood glucose levels, ensuring hemodynamic stability, and preventing complications like diabetic ketoacidosis (DKA) or fetal distress.
Glycemic Control During Labor and Delivery
Maintaining tight glycemic control during labor is critical in diabetic pregnancies to reduce neonatal complications, such as hypoglycemia. Blood glucose should be frequently monitored with hourly capillary blood checks. ACOG recommends keeping intrapartum glucose between 70 and 110 mg/dL. A common protocol runs a non-glucose-containing crystalloid such as lactated Ringer's or normal saline while glucose is in range, switches to or adds 5% dextrose at about 100 to 125 mL/h when glucose falls below 70 mg/dL or once active labor begins (labor is work, and glucose demand rises), and starts an intravenous regular insulin infusion at about 1 to 1.25 units/h when glucose exceeds 110 mg/dL, titrated against the hourly readings. Women with type 1 diabetes must never be left without insulin: they need a basal supply (infusion or long-acting insulin) with dextrose running alongside to prevent ketosis, whereas most women with diet-controlled gestational diabetes need no insulin in labor. Dextrose boluses are avoided because maternal hyperglycemia at delivery drives fetal insulin secretion and worsens neonatal hypoglycemia and acidosis. Proper glycemic management during labor helps minimize the risk of neonatal hypoglycemia (macrosomia is determined long before labor).
For a scheduled induction or cesarean, the usual evening dose of intermediate- or long-acting insulin is given the night before (some protocols reduce it by 20% to 50%), breakfast is skipped, the morning dose is withheld or reduced to one-third to one-half of the usual intermediate-acting dose, and the glucose and insulin infusions take over once the patient is in labor; an insulin pump can be continued at a reduced basal rate. After delivery, insulin requirements drop substantially, and insulin is restarted at roughly one-third to one-half of the end-of-pregnancy dose, which for many women is approximately half of the pre-pregnancy dose in the first days, particularly while breastfeeding, reflecting the abrupt loss of placental hormones and insulin resistance. Women with gestational diabetes can usually stop insulin at delivery. Frequent blood glucose checks remain essential to maintain appropriate control during the postpartum period.
| Element | Approach described |
|---|---|
| Monitoring | Hourly capillary blood glucose checks during labor |
| Target during labor | 70 to 110 mg/dL (ACOG) |
| If glucose exceeds 110 mg/dL | Start an intravenous regular insulin infusion, about 1 to 1.25 units/h, titrated hourly; type 1 diabetes always keeps a basal insulin supply |
| Fluid choice | Non-glucose-containing crystalloid while in range; 5% dextrose at 100 to 125 mL/h when glucose falls below 70 mg/dL or in active labor; no dextrose boluses |
| Insulin for a scheduled induction or cesarean | Usual (or reduced) evening basal dose the night before; morning dose withheld or cut to one-third to one-half; infusions take over in labor |
| Target during cesarean section | Same 70 to 110 mg/dL (up to 120 in some protocols), using a short-acting insulin infusion adjusted on hourly measurements |
| After delivery | Insulin requirements fall substantially; restart at one-third to one-half of the end-of-pregnancy dose (about half the pre-pregnancy dose for many) and continue frequent checks; gestational diabetes usually needs none |
Epidural Anesthesia for Labor
Epidural anesthesia is often preferred for labor in diabetic patients due to its advantages in pain control, reduced catecholamine release, and improved hemodynamic stability. Managing stress responses is critical for preventing placental insufficiency and fetal acidosis, conditions that can arise from elevated maternal catecholamines.
Labor analgesia is typically initiated with a dilute loading dose (for example 10 to 15 mL of 0.0625% to 0.125% bupivacaine with fentanyl 2 mcg/mL) rather than 0.25% bupivacaine, then maintained with the same dilute solution at 8 to 12 mL/h by continuous infusion or programmed intermittent bolus. This approach provides effective pain relief while minimizing motor block and hemodynamic change. For anticipated cesarean sections or operative deliveries, denser perineal anesthesia using 2-chloroprocaine or lidocaine with bicarbonate can provide adequate perineal relaxation and reduce the risk of birth trauma. Hypotension is prevented and treated promptly with left uterine displacement, a non-dextrose crystalloid coload, and phenylephrine: placental reserve is already reduced in diabetic pregnancies, and maternal hypotension translates into fetal acidosis more readily than in healthy women.
Anesthesia for Cesarean Section
Diabetic parturients undergoing cesarean sections require a comprehensive preoperative evaluation, especially those with long-standing diabetes and complications such as diabetic nephropathy, autonomic neuropathy, or pre-eclampsia. These patients may present additional risks, including hypertension, gastroparesis, cardiac dysfunction, and altered autonomic responses. Preoperative assessments should focus on renal function, cardiovascular status, and autonomic dysfunction to anticipate potential hemodynamic instability during anesthesia. Autonomic neuropathy (suggested by resting tachycardia, orthostatic hypotension, loss of heart rate variability, or gastroparesis) blunts the heart rate response to hypotension and to atropine, impairs the counter-regulatory response to hypoglycemia, and has been linked to unexpected bradycardia and cardiorespiratory arrest, so these patients need vigilant monitoring of volume status and pressor support at hand.
Epidural anesthesia is preferred over spinal anesthesia for cesarean sections in diabetic patients, particularly for those with autonomic neuropathy. The gradual onset of sympathetic blockade with epidural anesthesia helps prevent severe hypotension, which is exacerbated by autonomic dysfunction and decreased vascular tone. Epidural or combined spinal-epidural anesthesia, titrated gradually, offers better hemodynamic control than the rapid-onset hypotension of a single-shot spinal, which may not be well tolerated in diabetic patients with cardiovascular or autonomic disease. Spinal anesthesia remains acceptable for the otherwise well diabetic parturient: the neonatal acidosis seen with spinal anesthesia in early studies (Datta et al., 1982) was tied to maternal hypotension and dextrose loading, and it is avoided when hypotension is prevented with a non-dextrose coload and a prophylactic phenylephrine infusion.
Intraoperative glycemic control is crucial, with short-acting insulin administered via infusion and adjusted based on hourly blood glucose measurements. Target glucose levels are the same 70 to 110 mg/dL used in labor (values up to 120 mg/dL are accepted in some protocols), avoiding both hyperglycemia, which worsens neonatal hypoglycemia and acidosis, and hypoglycemia. Postoperative glucose monitoring should continue, and insulin therapy adjusted as maternal insulin sensitivity changes rapidly after delivery.
For patients undergoing general anesthesia, additional precautions are necessary. Diabetic parturients frequently have delayed gastric emptying due to gastroparesis, increasing the risk of aspiration. Preoperative administration of a non-particulate antacid, metoclopramide, and an H2-receptor antagonist helps mitigate this risk. Difficult airway management can also be a concern, particularly in patients with stiff joint syndrome (limited joint mobility from glycation of collagen, screened for with the prayer sign, an inability to press the palms and fingers flat together), which may limit atlanto-occipital extension and complicate intubation. Note that the metoclopramide used here for aspiration prophylaxis is omitted in a patient with pheochromocytoma (see the second half of this module). Therefore, equipment for managing difficult airways, including fiberoptic intubation devices, should be readily available in the operating room.
Postoperative Pain Management and Monitoring
Postoperative pain management is essential to minimize stress-induced fluctuations in glucose levels and ensure maternal comfort. Neuraxial morphine, administered intrathecally or epidurally, can provide effective pain relief for up to 24 hours. For patients who had general anesthesia, patient-controlled analgesia (PCA) with intravenous opioids such as morphine or hydromorphone is an alternative option. Nonsteroidal anti-inflammatory drugs (NSAIDs) may be used for breakthrough pain, though caution is advised in patients with renal dysfunction.
Diabetic patients are at a higher risk for postoperative infections, so strict aseptic techniques are vital during regional anesthesia. Diabetes is a known risk factor for spontaneous epidural abscesses, so postoperative monitoring should include regular glucose checks and vigilance for signs of infection, pulmonary edema, or cardiovascular instability, particularly in patients with pre-existing complications like nephropathy or pre-eclampsia.
